... the Spartan Trial — Journal of the American Society of Nephrology Effect of SGLT2 Inhibitors on the Proteinuria Reduction in Patients With IgA Nephropathy — Frontiers in Medicine Effect of Cyclophosphamide and Glucocorticoid Therapy in IgA Nephropathy: A Single-Center Retrospective Analysis — Kidney 360 Novartis Receives FDA Accelerated Approval for Vanrafia ...
IgA Nephropathy Treatment: 6 Keys To Maintaining Renal Function
... the Spartan Trial — Journal of the American Society of Nephrology Effect of SGLT2 Inhibitors on the Proteinuria Reduction in Patients With IgA Nephropathy — Frontiers in Medicine Effect of Cyclophosphamide and Glucocorticoid Therapy in IgA Nephropathy: A Single-Center Retrospective Analysis — Kidney 360 Novartis Receives FDA Accelerated Approval for Vanrafia ...
... — Kidney and Dialysis Novartis Receives FDA Accelerated Approval for Vanrafia (Atrasentan), the First and Only Selective Endothelin A Receptor Antagonist for Proteinuria Reduction in Primary IgA Nephropathy (IgAN) — Novartis FDA Approves First Drug To Decrease Urine Protein in IgA Nephropathy, a Rare Kidney Disease — U.S. ...
How Long Can You Live With Proteinuria? Understanding Outlook and Treatment
... — Kidney and Dialysis Novartis Receives FDA Accelerated Approval for Vanrafia (Atrasentan), the First and Only Selective Endothelin A Receptor Antagonist for Proteinuria Reduction in Primary IgA Nephropathy (IgAN) — Novartis FDA Approves First Drug To Decrease Urine Protein in IgA Nephropathy, a Rare Kidney Disease — U.S. ...
... Atrasentan (Vanrafia) — Atrasentan blocks endothelin receptors, helping to reduce pressure inside the glomeruli. Budesonide (Tarpeyo) — This is a type of steroid that works mainly in the small intestine, where much of the body’s IgA is made. By calming inflammation in this area, budesonide helps reduce IgA activity. ...
How To Reduce Protein in Urine: Treatment, Tips, and More
... Atrasentan (Vanrafia) — Atrasentan blocks endothelin receptors, helping to reduce pressure inside the glomeruli. Budesonide (Tarpeyo) — This is a type of steroid that works mainly in the small intestine, where much of the body’s IgA is made. By calming inflammation in this area, budesonide helps reduce IgA activity. ...
... These drugs include: ACE inhibitors, such as benazepril, captopril, enalapril, and lisinopril Angiotensin-receptor blockers, such as azilsartan, candesartan, irbesartan, and losartan Statins Immunosuppressants, such as corticosteroids and targeted-release budesonide (Tarpeyo) Endothelin A receptor antagonists, including atrasentan (Vanrafia) Dual endothelin ...
IgA Nephropathy Prognosis: 6 Factors That Affect Outcome
... These drugs include: ACE inhibitors, such as benazepril, captopril, enalapril, and lisinopril Angiotensin-receptor blockers, such as azilsartan, candesartan, irbesartan, and losartan Statins Immunosuppressants, such as corticosteroids and targeted-release budesonide (Tarpeyo) Endothelin A receptor antagonists, including atrasentan (Vanrafia) Dual endothelin ...
Join
